Vascular endothelial growth factor: An important molecular target of curcumin

References

• Abdel-Daim, M. M., and R. H. Abdou. 2015. Protective effects of diallyl sulfide and curcumin separately against thallium-induced toxicity in rats. Cell Journal (Yakhteh) 17:379.
   PubMed Web of Science ®Google Scholar
• Abdollahi, E., A. A. Momtazi, T. P. Johnston, and A. Sahebkar. 2017. Therapeutic Effects of Curcumin in Inflammatory and Immune-Mediated Diseases: A Nature-Made Jack-of-All-Trades? Journal of cellular physiology Jan 06. doi: 10.1002/jcp.25778. [Epub ahead of print]
   Web of Science ®Google Scholar
• ABE, Y., S. Hashimoto, and T. HORIE. 1999. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacological research 39:41–47.
   PubMed Web of Science ®Google Scholar
• Advani, S. H. 2010. Targeting mTOR pathway: A new concept in cancer therapy. Indian journal of medical and paediatric oncology: official journal of Indian Society of Medical & Paediatric Oncology Oct;31:132–136.
   PubMedGoogle Scholar
• Aflibercept (Eylea): Treatment of Neovascular (Wet) Age-Related Macular Degeneration (wAMD). 2015. Ottawa ON: Cadth 2015.
   Google Scholar
• Aggarwal, B. B. 2010. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annual review of nutrition Aug 21;30:173–199.
   PubMed Web of Science ®Google Scholar
• Aggarwal, B. B., K. B. Harikumar. 2009. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. The international journal of biochemistry & cell biology Jan;41:40–59.
   PubMed Web of Science ®Google Scholar
• Akman, A., E. Yilmaz, H. Mutlu, M. Ozdogan. 2009. Complete remission of psoriasis following bevacizumab therapy for colon cancer. Clinical and experimental dermatology 34:e202–e204.
   PubMed Web of Science ®Google Scholar
• Alitalo, K., P. Carmeliet. 2002. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer cell 1:219–227.
   PubMed Web of Science ®Google Scholar
• Anand, P., A. B. Kunnumakkara, R. A. Newman, B. B. Aggarwal. 2007. Bioavailability of curcumin: problems and promises. Molecular pharmaceutics 4:807–818.
   PubMed Web of Science ®Google Scholar
• Anand, P., B. Sung, A. B. Kunnumakkara, K. N. Rajasekharan, and B. B. Aggarwal. 2011. Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone: role of Michael acceptors and Michael donors. Biochemical pharmacology 82:1901.
   PubMed Web of Science ®Google Scholar
• Anthwal, A., B. K. Thakur, M. S. Rawat, D. S. Rawat, A. K. Tyagi, B. B. Aggarwal. 2014. Synthesis, characterization and in vitro anticancer activity of C-5 curcumin analogues with potential to inhibit TNF-alpha-induced NF-kappaB activation. BioMed research international 2014:524161.
   PubMed Web of Science ®Google Scholar
• Basnet, P., N. Skalko-Basnet. 2011. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules Jun 03;16:4567–4598.
   PubMed Web of Science ®Google Scholar
• Bayet-Robert, M., F. Kwiatowski, M. Leheurteur, F. Gachon, E. Planchat, C. Abrial, M.-A. Mouret-Reynier, X. Durando, C. Barthomeuf, P. Chollet. 2010. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer biology & therapy 9:8–14.
   PubMed Web of Science ®Google Scholar
• Bianchi, E., F. Scarinci, C. Grande, R. Plateroti, P. Plateroti, A. Plateroti, L. Fumagalli, P. Capozzi, J. Feher, and M. Artico. 2012. Immunohistochemical Profile and VEGF, TGF-β and PGE2 in Human Pterygium and Normal Conjunctiva: Experimental Study and Review of the Literature. International journal of immunopathology and pharmacology 25:607–615.
   PubMed Web of Science ®Google Scholar
• Binion, D. G., M. F. Otterson, P. Rafiee. 2008. Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition. Gut 57:1509–1517.
   PubMed Web of Science ®Google Scholar
• Bishnoi, M., K. Chopra, L. Rongzhu, and S. K. Kulkarni. 2011. Protective effect of curcumin and its combination with piperine (bioavailability enhancer) against haloperidol-associated neurotoxicity: cellular and neurochemical evidence. Neurotoxicity research 20:215–225.
   PubMed Web of Science ®Google Scholar
• Blasiak, J., G. Petrovski, Z. Veréb, A. Facskó, K. Kaarniranta. 2014. Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration. BioMed research international 2014:768026.
   Google Scholar
• Brenchley, P. 2000. Angiogenesis in inflammatory joint disease: a target for therapeutic intervention. Clinical & Experimental Immunology 121:426–429.
   PubMed Web of Science ®Google Scholar
• Brondino, N., S. Re, A. Boldrini, A. Cuccomarino, N. Lanati, F. Barale, P. Politi. 2014. Curcumin as a therapeutic agent in dementia: a mini systematic review of human studies. The Scientific World Journal. 2014:174282.
   Google Scholar
• Bry, M., R. Kivelä, T. Holopainen, A. Anisimov, T. Tammela, J. Soronen, J. Silvola, A. Saraste, M. Jeltsch, P. Korpisalo. 2010. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation 122:1725–1733.
   PubMed Web of Science ®Google Scholar
• Cao, J., Y. Liu, L. Jia, L. P. Jiang, C. Y. Geng, X. F. Yao, Y. Kong, B. N. Jiang, and L. F. Zhong. 2008. Curcumin attenuates acrylamide-induced cytotoxicity and genotoxicity in HepG2 cells by ROS scavenging. Journal of agricultural and food chemistry Dec 24;56:12059–12063.
   PubMed Web of Science ®Google Scholar
• Carroll, C. E., I. Benakanakere, C. Besch-Williford, M. R. Ellersieck, S. M. Hyder. 2009. Curcumin delays development of medroxyprogesterone acetate-accelerated 7, 12-dimethylbenz [a] anthracene-induced mammary tumors. Menopause (New York, NY). 17:178–184.
   Web of Science ®Google Scholar
• Carroll, C. E., M. R. Ellersieck, S. M. Hyder. 2008. Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells. Menopause 15:570–574.
   PubMed Web of Science ®Google Scholar
• Carroll, C. E., Y. Liang, I. Benakanakere, C. Besch-Williford, and S. M. Hyder. 2013. The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development. International journal of oncology Jan;42:179–187.
   PubMed Web of Science ®Google Scholar
• Carvalho Ferreira, L., A. S Arbab, B. Victorasso Jardim-Perassi, T. Ferraz Borin, N. R. S. Varma, A. Iskander, A. Shankar, M. M Ali, and D. Aparecida Pires de Campos Zuccari. 2015. Effect of curcumin on pro-angiogenic factors in the xenograft model of breast cancer. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 15:1285–1296.
   PubMed Web of Science ®Google Scholar
• Chakraborty, G., S. Jain, S. Kale, R. Raja, S. Kumar, R. Mishra, and G. C. Kundu. 2008. Curcumin suppresses breast tumor angiogenesis by abrogating osteopontin-induced VEGF expression. Mol Med Rep 1:641–646.
   PubMed Web of Science ®Google Scholar
• Chandran, B., A. Goel. 2012. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytotherapy research: PTR Nov;26:1719–1725.
   PubMed Web of Science ®Google Scholar
• Chang, Y.-C., W.-C. Chang, K.-H. Hung, D.-M. Yang, Y.-H. Cheng, Y.-W. Liao, L.-C. Woung, C.-Y. Tsai, C.-C. Hsu, and T.-C. Lin. 2014. The generation of induced pluripotent stem cells for macular degeneration as a drug screening platform: identification of curcumin as a protective agent for retinal pigment epithelial cells against oxidative stress. Frontiers in aging neuroscience 6:191.
   PubMed Web of Science ®Google Scholar
• Chen, S. S., A. MIChAel, and S. A. Butler-Manuel. 2012a. Advances in the Treatment of Ovarian Cancer—A Potential Role of Anti-inflammatory Phytochemicals. Discovery medicine 13:7–17.
   PubMed Web of Science ®Google Scholar
• Chin, D., P. Huebbe, K. Pallauf, G. Rimbach. 2013. Neuroprotective properties of curcumin in Alzheimer's disease-merits and limitations. Current medicinal chemistry 20:3955–3985.
   PubMed Web of Science ®Google Scholar
• Chrusciel, P., A. Sahebkar, M. Rembek-Wieliczko, M. C. Serban, S. Ursoniu, D. P. Mikhailidis, S. R. Jones, S. Mosteoru, M. J. Blaha, and S. S. Martin, et al. 2016. Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms. Atherosclerosis Oct;253:194–208.
   PubMed Web of Science ®Google Scholar
• Claesson-Welsh, L. 2003. Signal transduction by vascular endothelial growth factor receptors. In: Portland Press Limited.
   Google Scholar
• Clauss, M., M. Gerlach, H. Gerlach, J. Brett, F. Wang, P. Familletti, Y. Pan, J. Olander, D. Connolly, and D. Stern. 1990. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. The Journal of experimental medicine 172:1535–1545.
   PubMed Web of Science ®Google Scholar
• Cohen, M. H., J. Gootenberg, P. Keegan, R. Pazdur. 2007. FDA drug approval summary: bevacizumab (Avastin®) plus carboplatin and paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer. The Oncologist 12:713–718.
   PubMed Web of Science ®Google Scholar
• Dai, C., S. Tang, D. Li, K. Zhao, X. Xiao. 2015a. Curcumin attenuates quinocetone-induced oxidative stress and genotoxicity in human hepatocyte L02 cells. Toxicology mechanisms and methods 25:340–346.
   PubMed Web of Science ®Google Scholar
• Dai, F., X. Zhang, W. Shen, J. Chen, L. Liu, and G. Gao. 2015. liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors. OncoTargets and therapy 8:2601.
   PubMed Web of Science ®Google Scholar
• Decio, A., M. Cesca, F. Bizzaro, L. Porcu, R. Bettolini, P. Ubezio, G. Taraboletti, D. Belotti, and R. Giavazzi. 2015a. Cediranib combined with chemotherapy reduces tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts with different responsiveness to cisplatin. Clin Exp Metastasis Oct;32:647–658.
   PubMed Web of Science ®Google Scholar
• DiSilvestro, R. A., E. Joseph, S. Zhao, and J. Bomser. 2012. Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutrition journal 11:1.
   PubMed Web of Science ®Google Scholar
• Duan, W., Y. Chang, R. Li, Q. Xu, J. Lei, C. Yin, T. Li, Y. Wu, Q. Ma, and X. Li. 2014. Curcumin inhibits hypoxia inducible factor1alphainduced epithelialmesenchymal transition in HepG2 hepatocellular carcinoma cells. Mol Med Rep Nov;10:2505–2510.
   PubMed Web of Science ®Google Scholar
• Dunbar, J. A., P. Reddy, N. Davis-Lameloise, B. Philpot, T. Laatikainen, A. Kilkkinen, S. J. Bunker, J. D. Best, E. Vartiainen, and S. K. Lo. 2008. Depression: an important comorbidity with metabolic syndrome in a general population. Diabetes care 31:2368–2373.
   PubMed Web of Science ®Google Scholar
• Epstein, J., I. R. Sanderson, T. T. MacDonald. 2010. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. British journal of nutrition 103:1545–1557.
   PubMed Web of Science ®Google Scholar
• Esmaily, H., A. Sahebkar, M. Iranshahi, S. Ganjali, A. Mohammadi, G. Ferns, and M. Ghayour-Mobarhan. 2015a. An investigation of the effects of curcumin on anxiety and depression in obese individuals: a randomized controlled trial. Chinese journal of integrative medicine 21:332–338.
   PubMed Web of Science ®Google Scholar
• Farhangi, B., A. M. Alizadeh, H. Khodayari, S. Khodayari, M. J. Dehghan, V. Khori, A. Heidarzadeh, M. Khaniki, M. Sadeghiezadeh, and F. Najafi. 2015. Protective effects of dendrosomal curcumin on an animal metastatic breast tumor. European journal of pharmacology 758:188–196.
   PubMed Web of Science ®Google Scholar
• Ferrara, N. 2004. Vascular endothelial growth factor: basic science and clinical progress. Endocrine reviews 25:581–611.
   PubMed Web of Science ®Google Scholar
• Ferrara, N., H.-P. Gerber, J. LeCouter. 2003a. The biology of VEGF and its receptors. Nature medicine 9:669–676.
   PubMed Web of Science ®Google Scholar
• Folkman, J. The role of angiogenesis in tumor growth. Proceedings of the Seminars in cancer biology; 1992.
   Google Scholar
• Folkman, J., Y. Shing. 1992. Angiogenesis. The Journal of biological chemistry Jun 05;267:10931–10934. Epub 1992/06/05.
   PubMed Web of Science ®Google Scholar
• Fu, Z., X. Chen, S. Guan, Y. Yan, H. Lin, Z. C. Hua. 2015b. Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumor-derived VEGF in tumor model through modulating VEGF-VEGFR2 signaling pathway. Oncotarget Aug 14;6:19469–19482.
   PubMed Web of Science ®Google Scholar
• Ganjali, S., C. N. Blesso, M. Banach, M. Pirro, M. Majeed, A. Sahebkar. 2017. Effects of curcumin on HDL functionality. Pharmacological research Feb 10;119:208–218.
   PubMed Web of Science ®Google Scholar
• Ganjali, S., A. Sahebkar, E. Mahdipour, K. Jamialahmadi, S. Torabi, S. Akhlaghi, G. Ferns, S. M. Parizadeh, M. Ghayour-Mobarhan. 2014a. Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial. TheScientificWorldJournal 2014:898361.
   PubMed Web of Science ®Google Scholar
• Ghandadi, M., A. Sahebkar. 2016. Curcumin: An effective inhibitor of interleukin-6. Current pharmaceutical design 23(6):921–931.
   Web of Science ®Google Scholar
• Goel, A., A. B. Kunnumakkara, B. B. Aggarwal. 2008. Curcumin as “Curecumin”: from kitchen to clinic. Biochemical pharmacology 75:787–809.
   PubMed Web of Science ®Google Scholar
• Gong, P., M. Liu, G. Hong, Y. Li, P. Xue, M. Zheng, M. Wu, L. Shen, M. Yang, Z. Diao, et al. 2016. Curcumin improves LPS-induced preeclampsia-like phenotype in rat by inhibiting the TLR4 signaling pathway. Placenta May;41:45–52.
   PubMed Web of Science ®Google Scholar
• Gulbake, A., A. Jain, A. Jain, A. Jain, S. K. Jain. 2016. Insight to drug delivery aspects for colorectal cancer. World journal of gastroenterology 22:582.
   PubMed Web of Science ®Google Scholar
• Gupta, S. C., S. Patchva, B. B. Aggarwal. 2013. Therapeutic roles of curcumin: lessons learned from clinical trials. The AAPS journal Jan;15:195–218.
   PubMed Web of Science ®Google Scholar
• Gupta, S. C., A. K. Tyagi, P. Deshmukh-Taskar, M. Hinojosa, S. Prasad, B. B. Aggarwal. 2014. Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols. Archives of biochemistry and biophysics Oct 01;559:91–99.
   PubMed Web of Science ®Google Scholar
• Hamdy, R. C. 2002. Lessons learned from the Women's Health Initiative study. Southern medical journal Sep;95:951–952. Epub 2002/10/03.
   PubMed Web of Science ®Google Scholar
• Han, E. S., B. J. Monk. 2007. Bevacizumab in the treatment of ovarian cancer. Expert review of anticancer therapy 7:1339–1345.
   PubMed Web of Science ®Google Scholar
• Hartnett, M. E. 2014. Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity. Clinics in perinatology Dec;41:925–943. Epub 2014/12/03.
   PubMed Web of Science ®Google Scholar
• Heckman, C. A., T. Holopainen, M. Wirzenius, S. Keskitalo, M. Jeltsch, S. Ylä-Herttuala, S. R. Wedge, J. M. Jürgensmeier, K. Alitalo. 2008. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis. Cancer Research 68:4754–4762.
   PubMed Web of Science ®Google Scholar
• Hoesel, B., J. A. Schmid. 2013. The complexity of NF-kappaB signaling in inflammation and cancer. Molecular cancer Aug 02;12:86.
   PubMed Web of Science ®Google Scholar
• Hollborn, M., R. Chen, P. Wiedemann, A. Reichenbach, A. Bringmann, L. Kohen. 2013. Cytotoxic effects of curcumin in human retinal pigment epithelial cells. PloS one 8:e59603.
   PubMed Web of Science ®Google Scholar
• Houck, K. A., D. Leung, A. Rowland, J. Winer, N. Ferrara. 1992. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. Journal of Biological Chemistry 267:26031–26037.
   PubMed Web of Science ®Google Scholar
• Huang, C. Z., W. Z. Huang, G. Zhang, D. L. Tang. 2013. In vivo study on the effects of curcumin on the expression profiles of anti-tumour genes (VEGF, CyclinD1 and CDK4) in liver of rats injected with DEN. Molecular biology reports 40:5825–5831.
   PubMed Web of Science ®Google Scholar
• Hurwitz, H., L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth, W. Heim, J. Berlin, A. Baron, S. Griffing, E. Holmgren. 2004. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. New England journal of medicine 350:2335–2342.
   PubMed Web of Science ®Google Scholar
• Iqbal, M., S. D. Sharma, Y. Okazaki, M. Fujisawa, S. Okada. 2003. Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity. Pharmacology & toxicology 92:33–38.
   PubMedGoogle Scholar
• Ireson, C. R., D. J. Jones, S. Orr, M. W. Coughtrie, D. J. Boocock, M. L. Williams, P. B. Farmer, W. P. Steward, A. J. Gescher. 2002. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiology and Prevention Biomarkers 11:105–111.
   PubMed Web of Science ®Google Scholar
• Jeong, G. S., G. S. Oh, H. O. Pae, S. O. Jeong, Y. C. Kim, M. K. Shin, B. Y. Seo, S. Y. Han, H. S. Lee, J. G. Jeong, et al. 2006. Comparative effects of curcuminoids on endothelial heme oxygenase-1 expression: ortho-methoxy groups are essential to enhance heme oxygenase activity and protection. Experimental & molecular medicine Aug 31;38:393–400.
   PubMed Web of Science ®Google Scholar
• Jeong, S. J., W. Koh, E. O. Lee, H. J. Lee, H. J. Lee, H. Bae, J. Lu, S. H. Kim. 2011. Antiangiogenic phytochemicals and medicinal herbs. Phytotherapy research: PTR Jan;25:1–10.
   PubMed Web of Science ®Google Scholar
• Ji, R.-R., R. W. Gereau, M. Malcangio, G. R. Strichartz. 2009. MAP kinase and pain. Brain research reviews 60:135–148.
   PubMed Web of Science ®Google Scholar
• Jin, J., K. Sison, C. Li, R. Tian, M. Wnuk, H.-K. Sung, M. Jeansson, C. Zhang, M. Tucholska, N. Jones. 2012. Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function. Cell 151:384–399.
   PubMed Web of Science ®Google Scholar
• Jurenka, J. S. 2009. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Alternative medicine review: a journal of clinical therapeutic Jun;14:141–153.
   PubMed Web of Science ®Google Scholar
• Karimian, M. S., M. Pirro, T. P. Johnston, M. Majeed, A. Sahebkar. 2017. Curcumin and Endothelial Function: Evidence and Mechanisms of Protective Effects. Current pharmaceutical design 23(17):2462–2473.
   PubMed Web of Science ®Google Scholar
• Karimian, M. S., M. Pirro, M. Majeed, A. Sahebkar. 2017. Curcumin as a natural regulator of monocyte chemoattractant protein-1. Cytokine & growth factor reviews. Feb;33:55–63.
   PubMed Web of Science ®Google Scholar
• Kelany, M. E., T. M. Hakami, A. H. Omar. 2017. Curcumin improves the metabolic syndrome in high-fructose-diet-fed rats: role of TNF-alpha, NF-kappaB, and oxidative stress. Canadian journal of physiology and pharmacology. Feb;95:140–150.
   PubMed Web of Science ®Google Scholar
• Kiselyov, A., K. V. Balakin, S. E. Tkachenko. 2007. VEGF/VEGFR signalling as a target for inhibiting angiogenesis. Expert opinion on investigational drugs 16:83–107.
   PubMed Web of Science ®Google Scholar
• Kloesch, B., T. Becker, E. Dietersdorfer, H. Kiener, G. Steiner. 2013. Anti-inflammatory and apoptotic effects of the polyphenol curcumin on human fibroblast-like synoviocytes. International immunopharmacology Feb;15:400–405.
   PubMed Web of Science ®Google Scholar
• Koch, S., S. Tugues, X. Li, L. Gualandi, L. Claesson-Welsh. 2011. Signal transduction by vascular endothelial growth factor receptors. Biochemical Journal 437:169–183.
   PubMed Web of Science ®Google Scholar
• Krock, B. L., N. Skuli, M. C. Simon. 2011. Hypoxia-induced angiogenesis: good and evil. Genes & cancer Dec;2:1117–1133.
   PubMedGoogle Scholar
• Kumar, P., A. Kadakol, P. Krishna Shasthrula, N. Arunrao Mundhe, V. Sudhir Jamdade, C. C Barua, A. Bhanudas Gaikwad. 2015. Curcumin as an adjuvant to breast cancer treatment. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 15:647–656.
   PubMed Web of Science ®Google Scholar
• Kunnumakkara, A. B., P. Anand, B. B. Aggarwal. 2008. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett Oct 08;269:199–225.
   PubMed Web of Science ®Google Scholar
• Lee, K. W., J.-H. Kim, H. J. Lee, Y.-J. Surh. 2005. Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-κB transcriptional activity in MCF10A human breast epithelial cells. Antioxidants & redox signaling 7:1612–1620.
   PubMed Web of Science ®Google Scholar
• Lelli, D., A. Sahebkar, T. P. Johnston, C. Pedone. 2017. Curcumin use in pulmonary diseases: State of the art and future perspectives. Pharmacological research Jan;115:133–148.
   PubMed Web of Science ®Google Scholar
• Li, J., P. Wang, J. Ying, Z. Chen, S. Yu. 2016. Curcumin Attenuates Retinal Vascular Leakage by Inhibiting Calcium/Calmodulin-Dependent Protein Kinase II Activity in Streptozotocin-Induced Diabetes. Cellular Physiology and Biochemistry 39:1196–1208.
   PubMed Web of Science ®Google Scholar
• Li, X.-Y., Y.-Y. Feng, W. Dan, D. Pan, G.-F. Zhang, X.-L. Wang, G.-J. Hou. 2016. Study on the influence of curcumin on chemosensitivity of nephroblastoma cells. Asian Pacific journal of tropical medicine 9:801–805.
   PubMed Web of Science ®Google Scholar
• Liang, Y., R. A. Brekken, S. M. Hyder. 2006. Vascular endothelial growth factor induces proliferation of breast cancer cells and inhibits the anti-proliferative activity of anti-hormones. Endocrine-related cancer 13:905–919.
   PubMed Web of Science ®Google Scholar
• Liang, Y., S. M. Hyder. 2005. Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effects. Endocrinology 146:3632–3641.
   PubMed Web of Science ®Google Scholar
• Lin, J. K., and S. Y. Lin-Shiau. 2001. Mechanisms of cancer chemoprevention by curcumin. Proceedings of the National Science Council, Republic of China Part B, Life sciences Apr;25:59–66.
   Google Scholar
• Lin, S.-S., K.-C. Lai, S.-C. Hsu, J.-S. Yang, C.-L. Kuo, J.-P. Lin, Y.-S. Ma, C.-C. Wu, and J.-G. Chung. 2009. Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and-9 and Vascular Endothelial Growth Factor (VEGF). Cancer letters 285:127–133.
   PubMed Web of Science ®Google Scholar
• Liu, W., Y. Zhai, X. Heng, F. Y. Che, W. Chen, D. Sun, and G. Zhai. 2016. Oral bioavailability of curcumin: problems and advancements. Journal of drug targeting Sep;24:694–702.
   PubMed Web of Science ®Google Scholar
• Luo, L., H. Uehara, X. Zhang, S. K. Das, T. Olsen, D. Holt, J. M. Simonis, K. Jackman, N. Singh, and T. R. Miya. 2013. Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1. Elife 2:e00324.
   PubMed Web of Science ®Google Scholar
• Maheshwari, R. K., A. K. Singh, J. Gaddipati, and R. C. Srimal. 2006. Multiple biological activities of curcumin: a short review. Life sciences 78:2081–2087.
   PubMed Web of Science ®Google Scholar
• Manolova, Y., V. Deneva, L. Antonov, E. Drakalska, D. Momekova, N. Lambov. 2014. The effect of the water on the curcumin tautomerism: A quantitative approach. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 132:815–820.
   PubMed Web of Science ®Google Scholar
• Masoumi Moghaddam, S., A. Amini, D. L. Morris, and M. H. Pourgholami. 2012. Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer. Cancer metastasis reviews Jun;31:143–162.
   PubMed Web of Science ®Google Scholar
• Mintz-Hittner, H. A. 2012. Treatment of retinopathy of prematurity with vascular endothelial growth factor inhibitors. Early human development 88:937–941.
   PubMed Web of Science ®Google Scholar
• Mirzaei, H., G. Naseri, R. Rezaee, M. Mohammadi, Z. Banikazemi, H. R. Mirzaei, H. Salehi, M. Peyvandi, J. M. Pawelek, and A. Sahebkar. 2016. Curcumin: A new candidate for melanoma therapy? International journal of cancer Oct 15;139:1683–1695.
   PubMed Web of Science ®Google Scholar
• Mirzaei, H., A. Shakeri, B. Rashidi, A. Jalili, Z. Banikazemi, and A. Sahebkar. 2017. Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Jan;85:102–112.
   PubMed Web of Science ®Google Scholar
• Mohammadi, A., A. Sahebkar, M. Iranshahi, M. Amini, R. Khojasteh, M. Ghayour-Mobarhan, and G. A. Ferns. 2013. Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. Phytotherapy research: PTR Mar;27:374–379.
   PubMed Web of Science ®Google Scholar
• Mohankumar, K., S. Sridharan, S. Pajaniradje, V. K. Singh, L. Ronsard, A. C. Banerjea, D. B. Somasundaram, M. S. Coumar, L. Periyasamy, and R. Rajagopalan. 2015. BDMC-A, an analog of curcumin, inhibits markers of invasion, angiogenesis, and metastasis in breast cancer cells via NF-κB pathway—A comparative study with curcumin. Biomedicine & Pharmacotherapy 74:178–186.
   PubMed Web of Science ®Google Scholar
• Momtazi, A. A., G. Derosa, P. Maffioli, M. Banach, A. Sahebkar. 2016. Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases. Molecular diagnosis & therapy Aug;20:335–345.
   PubMed Web of Science ®Google Scholar
• Momtazi, A. A., A. Sahebkar. 2016. Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile. Current pharmaceutical design 22:4386–4397.
   PubMed Web of Science ®Google Scholar
• Momtazi, A. A., F. Shahabipour, S. Khatibi, T. P. Johnston, M. Pirro, A. Sahebkar. 2016. Curcumin as a MicroRNA Regulator in Cancer: A Review. Reviews of physiology, biochemistry and pharmacology 171:1–38.
   PubMed Web of Science ®Google Scholar
• Moon, D. O., M. O. Kim, Y. H. Choi, Y. M. Park, G. Y. Kim. 2010. Curcumin attenuates inflammatory response in IL-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model. International immunopharmacology May;10:605–610.
   PubMed Web of Science ®Google Scholar
• Nagaraju, G. P., S. Zhu, J. E. Ko, N. Ashritha, R. Kandimalla, J. P. Snyder, M. Shoji, B. F. El-Rayes. 2015. Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer. Cancer Lett Feb 28;357:557–565.
   PubMed Web of Science ®Google Scholar
• Nagpal, M., S. Sood. 2013. Role of curcumin in systemic and oral health: An overview. Journal of natural science, biology, and medicine Jan;4:3–7.
   PubMedGoogle Scholar
• Narayanan, S., K. Callis-Duffin, J. Batten, N. Agarwal. 2010. Improvement of psoriasis during sunitinib therapy for renal cell carcinoma. The American journal of the medical sciences 339:580–581.
   PubMed Web of Science ®Google Scholar
• Nguyen, T. A., A. J. Friedman. 2013. Curcumin: a novel treatment for skin-related disorders. Journal of drugs in dermatology: JDD Oct;12:1131–1137.
   PubMed Web of Science ®Google Scholar
• Niu, G., X. Chen. 2010. Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. Current drug targets Aug;11:1000–1017.
   PubMed Web of Science ®Google Scholar
• Pajusola, K., O. Aprelikova, G. Pelicci, H. Weich, L. Claesson-Welsh, K. Alitalo. 1994. Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Oncogene 9:3545–3555.
   PubMed Web of Science ®Google Scholar
• Pan, M.-H., T.-M. Huang, J.-K. Lin. 1999. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug metabolism and disposition 27:486–494.
   PubMed Web of Science ®Google Scholar
• Panahi, Y., Y. Ahmadi, M. Teymouri, T. P. Johnston, A. Sahebkar. 2016. Curcumin as a Potential Candidate for Treating Hyperlipidemia: A Review of Cellular and Metabolic Mechanisms. Journal of cellular physiology Dec 24. doi: 10.1002/jcp.25756. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Panahi, Y., G. H. Alishiri, S. Parvin, A. Sahebkar. 2016. Mitigation of Systemic Oxidative Stress by Curcuminoids in Osteoarthritis: Results of a Randomized Controlled Trial. Journal of dietary supplements 13:209–220.
   PubMedGoogle Scholar
• Panahi, Y., R. Badeli, G. R. Karami, A. Sahebkar. 2015. Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder. Phytotherapy research: PTR Jan;29:17–21.
   PubMed Web of Science ®Google Scholar
• Panahi, Y., M. Ghanei, S. Bashiri, A. Hajihashemi, A. Sahebkar. 2015. Short-term Curcuminoid Supplementation for Chronic Pulmonary Complications due to Sulfur Mustard Intoxication: Positive Results of a Randomized Double-blind Placebo-controlled Trial. Drug research Nov;65:567–573. Epub 2014/10/01.
   PubMed Web of Science ®Google Scholar
• Panahi, Y., M. S. Hosseini, N. Khalili, E. Naimi, L. E. Simental-Mendia, M. Majeed, A. Sahebkar. 2016. Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Aug;82:578–582.
   PubMed Web of Science ®Google Scholar
• Panahi, Y., M. S. Hosseini, N. Khalili, E. Naimi, S. S. Soflaei, M. Majeed, A. Sahebkar. 2016. Effects of supplementation with curcumin on serum adipokine concentrations: A randomized controlled trial. Nutrition Oct;32:1116–1122.
   PubMed Web of Science ®Google Scholar
• Panahi, Y., N. Khalili, M. S. Hosseini, M. Abbasinazari, A. Sahebkar. 2014. Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: results of a randomized controlled trial. Complementary therapies in medicine Oct;22:851–857.
   PubMed Web of Science ®Google Scholar
• Panahi, Y., N. Khalili, E. Sahebi, S. Namazi, M. S. Karimian, M. Majeed, A. Sahebkar. 2017. Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial. Inflammopharmacology Feb;25:25–31.
   PubMed Web of Science ®Google Scholar
• Panahi, Y., P. Kianpour, R. Mohtashami, R. Jafari, L. E. Simental-Mendia, A. Sahebkar. 2016. Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial. Journal of cardiovascular pharmacology Sep;68:223–229.
   PubMed Web of Science ®Google Scholar
• Panahi, Y., A. R. Rahimnia, M. Sharafi, G. Alishiri, A. Saburi, A. Sahebkar. 2014a. Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. Phytotherapy research: PTR Nov;28:1625–1631.
   PubMed Web of Science ®Google Scholar
• Panahi, Y., A. Saadat, F. Beiraghdar, A. Sahebkar. 2014. Adjuvant Therapy with Bioavailability‐Boosted Curcuminoids Suppresses Systemic Inflammation and Improves Quality of Life in Patients with Solid Tumors: A Randomized Double‐Blind Placebo‐Controlled Trial. Phytotherapy Research 28:1461–1467.
   PubMed Web of Science ®Google Scholar
• Panahi, Y., A. Sahebkar, M. Amiri, S. M. Davoudi, F. Beiraghdar, S. L. Hoseininejad, M. Kolivand. 2012. Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial. The British journal of nutrition Oct;108:1272–1279.
   PubMed Web of Science ®Google Scholar
• Panahi, Y., A. Sahebkar, S. Parvin, A. Saadat. 2012. A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications. Annals of clinical biochemistry Nov;49:580–588. Epub 2012/10/06.
   PubMed Web of Science ®Google Scholar
• Park, C., D. O. Moon, I. W. Choi, B. T. Choi, T. J. Nam, C. H. Rhu, T. K. Kwon, W. H. Lee, G. Y. Kim, Y. H. Choi. 2007. Curcumin induces apoptosis and inhibits prostaglandin E(2) production in synovial fibroblasts of patients with rheumatoid arthritis. International journal of molecular medicine Sep;20:365–372.
   PubMed Web of Science ®Google Scholar
• Pertl, L., G. Steinwender, C. Mayer, S. Hausberger, E.-M. Pöschl, W. Wackernagel, A. Wedrich, Y. El-Shabrawi, A. Haas. 2015. A systematic review and meta-analysis on the safety of vascular endothelial growth factor (VEGF) inhibitors for the treatment of retinopathy of prematurity. PloS one 10:e0129383.
   PubMed Web of Science ®Google Scholar
• Premanand, C., M. Rema, M. Z. Sameer, M. Sujatha, M. Balasubramanyam. 2006. Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions. Investigative ophthalmology & visual science 47:2179–2184.
   PubMed Web of Science ®Google Scholar
• Priyanka, A., S. S. Anusree, V. M. Nisha, K. G. Raghu. 2014. Curcumin improves hypoxia induced dysfunctions in 3T3-L1 adipocytes by protecting mitochondria and down regulating inflammation. BioFactors Sep-Oct;40:513–523.
   PubMed Web of Science ®Google Scholar
• Pulido-Moran, M., J. Moreno-Fernandez, C. Ramirez-Tortosa, M. Ramirez-Tortosa. 2016. Curcumin and health. Molecules 21:264.
   PubMed Web of Science ®Google Scholar
• Rahmani, S., S. Asgary, G. Askari, M. Keshvari, M. Hatamipour, A. Feizi, A. Sahebkar. 2016. Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial. Phytotherapy research: PTR Sep;30:1540–1548.
   PubMed Web of Science ®Google Scholar
• Rajitha, B., G. P. Nagaraju, W. L. Shaib, O. B. Alese, J. P. Snyder, M. Shoji, S. Pattnaik, A. Alam, B. F. El‐Rayes. 2016. Novel synthetic curcumin analogs as potent antiangiogenic agents in colorectal cancer. Molecular carcinogenesis
   PubMed Web of Science ®Google Scholar
• Ramakrishnan, S., V. Anand, S. Roy. 2014. Vascular endothelial growth factor signaling in hypoxia and inflammation. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology Mar;9:142–160.
   PubMed Web of Science ®Google Scholar
• Ramezani, M., M. Hatamipour, A. Sahebkar. 2017. Promising Anti-tumor properties of Bisdemethoxycurcumin: A Naturally Occurring Curcumin Analogue. Journal of cellular physiology Jan 11. doi:10.1002/jcp.25795. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Ravindran, J., S. Prasad, B. B. Aggarwal. 2009. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? The AAPS journal Sep;11:495–510.
   PubMed Web of Science ®Google Scholar
• Recio, M. C., I. Andujar, J. L. Rios. 2012. Anti-inflammatory agents from plants: progress and potential. Curr Med Chem 19:2088–2103.
   PubMed Web of Science ®Google Scholar
• Reuter, S., S. C. Gupta, M. M. Chaturvedi, B. B. Aggarwal. 2010. Oxidative stress, inflammation, and cancer: how are they linked? Free radical biology & medicine Dec 01;49:1603–1616.
   PubMed Web of Science ®Google Scholar
• Roskoski, R. 2005. Src kinase regulation by phosphorylation and dephosphorylation. Biochemical and biophysical research communications 331:1–14.
   PubMed Web of Science ®Google Scholar
• Ruby, A., G. Kuttan, K. D. Babu, K. Rajasekharan, R. Kuttan. 1995. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer letters 94:79–83.
   PubMed Web of Science ®Google Scholar
• Ruscito, I., M. L. Gasparri, C. Marchetti, B. C. De Medici, I. Palaia, S. Imboden, M. D. Mueller, A. Papadia, and L. Muzii. 2016. Cediranib in ovarian cancer: state of the art and future perspectives. Tumor Biology 37:2833–2839.
   PubMed Web of Science ®Google Scholar
• Sahebkar, A. 2010. Molecular mechanisms for curcumin benefits against ischemic injury. Fertility and sterility Oct;94:e75–76; author reply e77.
   PubMed Web of Science ®Google Scholar
• Sahebkar, A. 2013. Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? BioFactors Mar-Apr;39:197–208.
   PubMed Web of Science ®Google Scholar
• Sahebkar, A. 2014a. Are Curcuminoids Effective C‐Reactive Protein‐Lowering Agents in Clinical Practice? Evidence from a Meta‐Analysis. Phytotherapy research. 28:633–642.
   PubMed Web of Science ®Google Scholar
• Sahebkar, A. 2014b. Curcuminoids for the management of hypertriglyceridaemia. Nature reviews Cardiology. Feb;11:123.
   PubMed Web of Science ®Google Scholar
• Sahebkar, A., Y. Henrotin. 2016. Analgesic Efficacy and Safety of Curcuminoids in Clinical Practice: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Pain medicine. Jun;17:1192–1202.
   PubMed Web of Science ®Google Scholar
• Sahebkar, A., A. Mohammadi, A. Atabati, S. Rahiman, S. Tavallaie, M. Iranshahi, S. Akhlaghi, G. A. Ferns, M. Ghayour-Mobarhan. 2013. Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals. Phytotherapy research: PTR. Dec;27:1883–1888.
   PubMed Web of Science ®Google Scholar
• Sahebkar, A., N. Saboni, M. Pirro, M. Banach. 2017. Curcumin: An effective adjunct in patients with statin-associated muscle symptoms? Journal of cachexia, sarcopenia and muscle. Feb;8:19–24.
   PubMed Web of Science ®Google Scholar
• Sethi, G., B. Sung, B. B. Aggarwal. 2008. Nuclear factor-kappaB activation: from bench to bedside. Experimental biology and medicine. Jan;233:21–31.
   PubMed Web of Science ®Google Scholar
• Shao, Z. M., Z. Z. Shen, C. H. Liu, M. R. Sartippour, V. L. Go, D. Heber, M. Nguyen. 2002. Curcumin exerts multiple suppressive effects on human breast carcinoma cells. International Journal of Cancer. 98:234–240.
   PubMed Web of Science ®Google Scholar
• Sharma, R. A., S. A. Euden, S. L. Platton, D. N. Cooke, A. Shafayat, H. R. Hewitt, T. H. Marczylo, B. Morgan, D. Hemingway, S. M. Plummer. 2004. Phase I clinical trial of oral curcumin. Clinical Cancer Research. 10:6847–6854.
   PubMed Web of Science ®Google Scholar
• Shibuya, M. 2011a. Involvement of Flt-1 (VEGF receptor-1) in cancer and preeclampsia. Proceedings of the Japan Academy, Series B. 87:167–178.
   Google Scholar
• Shibuya, M. 2011b. Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies. Genes & cancer. Dec;2:1097–1105.
   PubMedGoogle Scholar
• Shibuya, M. 2014. VEGF-VEGFR signals in health and disease. Biomol Ther (Seoul). 22:1–9.
   PubMed Web of Science ®Google Scholar
• Shibuya, M., L. Claesson-Welsh. 2006. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Experimental cell research. 312:549–560.
   PubMed Web of Science ®Google Scholar
• Shinkaruk, S., M. Bayle, G. Lain, G. Deleris. 2003. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy. Current Medicinal Chemistry-Anti-Cancer Agents. 3:95–117.
   PubMedGoogle Scholar
• Shoba, G., D. Joy, T. Joseph, M. Majeed, R. Rajendran, P. Srinivas. 1998. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta medica. 64:353–356.
   PubMed Web of Science ®Google Scholar
• Song, D., J. L. Dunaief. 2013. Retinal iron homeostasis in health and disease. Frontiers in aging neuroscience. 5:24.
   PubMed Web of Science ®Google Scholar
• Soung, Y. H., J. Chung. 2011. Curcumin inhibition of the functional interaction between integrin α6β4 and the epidermal growth factor receptor. Molecular cancer therapeutics. 10:883–891.
   PubMed Web of Science ®Google Scholar
• Squires, M. S., E. A. Hudson, L. Howells, S. Sale, C. E. Houghton, J. L. Jones, L. H. Fox, M. Dickens, S. A. Prigent, M. M. Manson. 2003. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochemical pharmacology. 65:361–376.
   PubMed Web of Science ®Google Scholar
• Strofer, M., W. Jelkmann, R. Depping. 2011. Curcumin decreases survival of Hep3B liver and MCF-7 breast cancer cells: the role of HIF. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft [et al]. Jul;187:393–400.
   PubMed Web of Science ®Google Scholar
• Sun, X.-D., X.-E. Liu, D.-S. Huang. 2012. Curcumin induces apoptosis of triple-negative breast cancer cells by inhibition of EGFR expression. Molecular medicine reports. 6:1267–1270.
   PubMed Web of Science ®Google Scholar
• Tagawa, T., R. Morgan, Y. Yen, J. Mortimer. 2011. Ovarian cancer: opportunity for targeted therapy. Journal of oncology. 2012:682480.
   PubMedGoogle Scholar
• Takahashi, S. 2011. Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy. Biological and Pharmaceutical Bulletin. 34:1785–1788.
   PubMed Web of Science ®Google Scholar
• Tammela, T., G. Zarkada, E. Wallgard, A. Murtomäki, S. Suchting, M. Wirzenius, M. Waltari, M. Hellström, T. Schomber, R. Peltonen. 2008. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature. 454:656–660.
   PubMed Web of Science ®Google Scholar
• Tan, C., L. Zhang, X. Cheng, X. F. Lin, R. R. Lu, J. D. Bao, H. X. Yu. 2015. Curcumin inhibits hypoxia-induced migration in K1 papillary thyroid cancer cells. Experimental biology and medicine. Jul;240:925–935.
   Web of Science ®Google Scholar
• Teymouri, M., M. Pirro, T. P. Johnston, A. Sahebkar. 2016. Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features. BioFactors May 6;43(3):331–346.
   PubMed Web of Science ®Google Scholar
• Thulasiraman, P., D. J. McAndrews, I. Q. Mohiudddin. 2014. Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells. BMC cancer. 14:1.
   PubMed Web of Science ®Google Scholar
• Visioli, F., A. Davalos. 2011. Polyphenols and cardiovascular disease: a critical summary of the evidence. Mini reviews in medicinal chemistry. 11:1186–1190.
   PubMed Web of Science ®Google Scholar
• Wolff, J. E., R. E. Brown, J. Buryanek, S. Pfister, T. S. Vats, M. E. Rytting. 2012. Preliminary experience with personalized and targeted therapy for pediatric brain tumors. Pediatric blood & cancer. 59:27–33.
   PubMed Web of Science ®Google Scholar
• Woo, J. M., D. Y. Shin, S. J. Lee, Y. Joe, M. Zheng, J. H. Yim, Z. Callaway, H. T. Chung. 2012. Curcumin protects retinal pigment epithelial cells against oxidative stress via induction of heme oxygenase-1 expression and reduction of reactive oxygen. Molecular vision. 18:901–908.
   PubMed Web of Science ®Google Scholar
• Wright, J. S. 2002. Predicting the antioxidant activity of curcumin and curcuminoids. Journal of Molecular Structure: THEOCHEM. 591:207–217.
   Web of Science ®Google Scholar
• Xia, Y.-P., B. Li, D. Hylton, M. Detmar, G. D. Yancopoulos, J. S. Rudge. 2003. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood. 102:161–168.
   PubMed Web of Science ®Google Scholar
• Xie, P., W. Zhang, S. Yuan, Z. Chen, Q. Yang, D. Yuan, F. Wang, and Q. Liu. 2012. Suppression of experimental choroidal neovascularization by curcumin in mice. PloS one. 7:e53329.
   PubMed Web of Science ®Google Scholar
• Yan, H.-X., Y. Wang, X.-N. Yang, L.-X. Fu, D.-M. Tang. 2013. A new selective vascular endothelial growth factor receptor 2 inhibitor ablates disease in a mouse model of psoriasis. Molecular medicine reports. 8:434–438.
   PubMed Web of Science ®Google Scholar
• Yang, K.-Y., L.-C. Lin, T.-Y. Tseng, S.-C. Wang, and T.-H. Tsai. 2007. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC–MS/MS. Journal of chromatography B. 853:183–189.
   PubMed Web of Science ®Google Scholar
• Yao, Q., Y. Lin, X. Li, X. Shen, J. Wang, and C. Tu. 2013. Curcumin ameliorates intrahepatic angiogenesis and capillarization of the sinusoids in carbon tetrachloride-induced rat liver fibrosis. Toxicology letters. Sep 12;222:72–82.
   PubMed Web of Science ®Google Scholar
• Yoshida, S., M. Ono, T. Shono, H. Izumi, T. Ishibashi, H. Suzuki, and M. Kuwano. 1997. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Molecular and cellular biology. 17:4015–4023.
   PubMed Web of Science ®Google Scholar
• Young, B. C., R. J. Levine, and S. A. Karumanchi. 2010. Pathogenesis of preeclampsia. Annual Review of Pathological Mechanical Disease. 5:173–192.
   PubMed Web of Science ®Google Scholar
• Zabihi, N. A., M. Pirro, T. P. Johnston, and A. Sahebkar. 2016. Is there a role for curcumin supplementation in the treatment of non-alcoholic fatty liver disease? The data suggest yes. Current pharmaceutical design. Oct 10;23(7):969–982.
   Web of Science ®Google Scholar
• Zhan, Y., Y. Chen, R. Liu, H. Zhang, and Y. Zhang. 2014. Potentiation of paclitaxel activity by curcumin in human breast cancer cell by modulating apoptosis and inhibiting EGFR signaling. Archives of pharmacal research. 37:1086–1095.
   PubMed Web of Science ®Google Scholar
• Zhang, F., Z. Zhang, L. Chen, D. Kong, X. Zhang, C. Lu, Y. Lu, and S. Zheng. 2014. Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells. Journal of cellular and molecular medicine. 18:1392–1406.
   PubMed Web of Science ®Google Scholar
• Zhang, Z.-J., L.-X. Zhao, D.-L. Cao, X. Zhang, Y.-J. Gao, and C. Xia. 2012. Curcumin inhibits LPS-induced CCL2 expression via JNK pathway in C6 rat astrocytoma cells. Cellular and molecular neurobiology. 32:1003–1010.
   PubMed Web of Science ®Google Scholar
• Zhao, L. X., B. C. Jiang, X. B. Wu, D. L. Cao, and Y. J. Gao. 2014. Ligustilide attenuates inflammatory pain via inhibition of NFκB‐mediated chemokines production in spinal astrocytes. European Journal of Neuroscience. 39:1391–1402.
   PubMed Web of Science ®Google Scholar
• Zhao, W., Y. Wang, Y. Wang, N. Gao, Z. Han, and H. Yu. 2015. Potential anti‐cancer effect of curcumin in human lung squamous cell carcinoma. Thoracic Cancer. 6:508–516.
   PubMed Web of Science ®Google Scholar
• Zhong, Y., T. Liu, Z. Guo. 2012. Curcumin inhibits ox-LDL-induced MCP-1 expression by suppressing the p38MAPK and NF-κB pathways in rat vascular smooth muscle cells. Inflammation Research. 61:61–67.
   PubMed Web of Science ®Google Scholar
• Zhu, W., Y. Wu, Y. F. Meng, J. Y. Wang, M. Xu, J. J. Tao, J. Lu. 2015. Effect of curcumin on aging retinal pigment epithelial cells. Drug design, development and therapy. 9:5337–5344.
   PubMed Web of Science ®Google Scholar